Minesh P Mehta Selected Research

Irinotecan (Camptosar)

1/2019	Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420.
1/2004	Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Minesh P Mehta Research Topics

Disease

98	Neoplasms (Cancer) 10/2022 - 08/2002
88	Brain Neoplasms (Brain Tumor) 10/2022 - 06/2002
55	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2004
38	Glioma (Gliomas) 02/2022 - 06/2002
26	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2005
24	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 02/2003
10	Lung Neoplasms (Lung Cancer) 01/2022 - 02/2003
5	Meningioma (Meningiomas) 06/2022 - 09/2010
5	Fatigue 02/2022 - 08/2010
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 01/2003
4	Necrosis 01/2022 - 06/2015
4	Pneumonia (Pneumonitis) 01/2021 - 11/2010
4	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2016
4	Lymphoma (Lymphomas) 01/2018 - 02/2007
4	Thrombocytopenia (Thrombopenia) 01/2018 - 07/2004
4	Oligodendroglioma 05/2017 - 09/2012
4	Cognitive Dysfunction 01/2015 - 11/2004
4	Disease Progression 02/2014 - 06/2008
3	Adenocarcinoma 12/2021 - 10/2016
3	Neurologic Manifestations (Neurological Manifestations) 11/2020 - 01/2010
3	Hypertension (High Blood Pressure) 01/2020 - 10/2008
3	Esophageal Neoplasms (Esophageal Cancer) 01/2017 - 08/2016
3	Neutropenia 02/2014 - 01/2003
3	Radiation Pneumonitis 12/2013 - 07/2011
2	Malignant Mesothelioma 04/2022 - 05/2021
2	Epilepsy (Aura) 02/2022 - 03/2016
2	Adenocarcinoma of Lung 01/2022 - 10/2016
2	Sepsis (Septicemia) 01/2021 - 11/2020
2	Pain (Aches) 11/2020 - 12/2005
2	Wounds and Injuries (Trauma) 08/2020 - 01/2017
2	Gliosarcoma 01/2020 - 12/2012
2	Lymphopenia (Lymphocytopenia) 01/2018 - 08/2010
2	Diarrhea 01/2018 - 01/2004
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2018 - 02/2007
2	Esophagitis 01/2016 - 11/2010
2	Edema (Dropsy) 04/2014 - 01/2010

Drug/Important Bio-Agent (IBA)

28	Temozolomide (Temodar)FDA LinkGeneric 04/2021 - 04/2003
12	motexafin gadoliniumIBA 11/2011 - 08/2002
8	ErbB Receptors (EGF Receptor)IBA 01/2022 - 12/2009
8	Biological ProductsIBA 01/2022 - 07/2004
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2004
7	Bevacizumab (Avastin)FDA Link 01/2021 - 01/2014
6	Procarbazine (Matulane)FDA Link 10/2022 - 09/2012
6	Vincristine (Oncovin)FDA LinkGeneric 10/2022 - 09/2012
6	Lomustine (CCNU)FDA Link 10/2022 - 09/2012
5	Pharmaceutical PreparationsIBA 02/2022 - 01/2006
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 07/2011
5	Anticonvulsants (Antiepileptic Drugs)IBA 03/2016 - 01/2004
4	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2022 - 09/2005
4	Tyrosine Kinase InhibitorsIBA 01/2021 - 08/2010
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020 - 05/2012
4	TOR Serine-Threonine KinasesIBA 01/2018 - 12/2009
4	Protons (Proton)IBA 11/2016 - 01/2016
4	Thalidomide (Thalomid)FDA Link 01/2013 - 05/2008
4	Carmustine (FIVB)FDA Link 11/2005 - 01/2004
3	Memantine (Namenda)FDA Link 01/2020 - 10/2013
3	Phosphotransferases (Kinase)IBA 01/2020 - 05/2012
3	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 12/2012
3	DNA (Deoxyribonucleic Acid)IBA 09/2017 - 02/2012
3	Alkylating AgentsIBA 03/2014 - 04/2003
3	SteroidsIBA 03/2012 - 01/2007
3	EnzymesIBA 10/2011 - 01/2004
3	Lapatinib (GW572016)FDA Link 10/2011 - 01/2007
2	B7-H1 AntigenIBA 01/2022 - 01/2021
2	Endothelial Growth FactorsIBA 01/2022 - 07/2011
2	mesoglycanIBA 01/2021 - 01/2021
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021 - 08/2010
2	Hormones (Hormone)IBA 01/2021 - 01/2020
2	Estrogen ReceptorsIBA 01/2021 - 01/2020
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2020 - 10/2011
2	Histones (Histone)IBA 01/2020 - 04/2019
2	Lipase (Acid Lipase)FDA Link 01/2020 - 01/2018
2	Transaminases (Aminotransferases)IBA 01/2020 - 10/2008
2	TIC10 compoundIBA 10/2019 - 04/2019
2	Dexamethasone (Maxidex)FDA LinkGeneric 04/2019 - 01/2019
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 01/2004
2	tipifarnib (R115777)IBA 01/2018 - 12/2011
2	Everolimus FDA Link 01/2018 - 08/2013
2	MethyltransferasesIBA 09/2017 - 09/2008
2	Proteins (Proteins, Gene)FDA Link 04/2014 - 07/2011
2	Sirolimus (Rapamycin)FDA Link 04/2014 - 12/2009

Therapy/Procedure

138	Radiotherapy 10/2022 - 06/2002
69	Therapeutics 06/2022 - 01/2003
41	Drug Therapy (Chemotherapy) 10/2022 - 01/2003
18	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 02/2014 - 02/2003
7	Re-Irradiation 06/2022 - 06/2008
5	Conformal Radiotherapy 08/2011 - 03/2006
4	Immunotherapy 01/2022 - 06/2015
4	Length of Stay 11/2021 - 08/2016
4	Chemoradiotherapy 03/2016 - 09/2004
3	Particle Accelerators 10/2021 - 12/2005
3	Retreatment 01/2021 - 01/2010
3	Cranial Irradiation 05/2014 - 12/2010
2	Patient Readmission 11/2021 - 08/2020
2	Craniotomy 11/2021 - 10/2018
2	Molecular Targeted Therapy 01/2021 - 12/2012
2	Salvage Therapy 11/2018 - 01/2018
2	Brachytherapy 11/2018 - 05/2016
2	Drug Tapering 11/2016 - 08/2010
2	Proton Therapy 11/2016 - 08/2011